Recruiting Lupus Studies in Fremont
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)
The primary purpose of this study is to evaluate the efficacy, safety, and tolerability of IMVT-1402 in participants with Cutaneous Lupus Erythematosus. The study will consist of 3 periods: Period 1...
Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
The goal of this clinical study is to test how edecesertib (formerly known as GS-5718) can be useful in treating Cutaneous Lupus Erythematosus (CLE) in participants with CLE. Information on what is ha...
About Lupus Clinical Trials in Fremont
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.
There are currently 2 lupus clinical trials recruiting participants in Fremont, CA. These studies are seeking a combined 89 participants. Research is being sponsored by Immunovant Sciences GmbH, Gilead Sciences. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Clinical Trials in Fremont — FAQ
Are there lupus clinical trials in Fremont?
Yes, there are 2 lupus clinical trials currently recruiting in Fremont, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fremont?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fremont research site will contact you about next steps.
Are clinical trials in Fremont free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fremont studies also compensate for your time and travel.
What lupus treatments are being tested?
The 2 active trials in Fremont are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.
Data updated March 2, 2026 from ClinicalTrials.gov